Carisma Therapeutics Inc
NASDAQ:CARM

Watchlist Manager
Carisma Therapeutics Inc Logo
Carisma Therapeutics Inc
NASDAQ:CARM
Watchlist
Price: 0.42 USD 3.73% Market Closed
Market Cap: 17.6m USD

Wall Street
Price Targets

CARM Price Targets Summary
Carisma Therapeutics Inc

Wall Street analysts forecast CARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARM is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Lowest
Price Target
1.01 USD
140% Upside
Average
Price Target
1.02 USD
143% Upside
Highest
Price Target
1.05 USD
150% Upside
Carisma Therapeutics Inc Competitors:
Price Targets
2616
CStone Pharmaceuticals
33% Downside
1952
Everest Medicines Ltd
15% Downside
DSGN
Design Therapeutics Inc
103% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
6% Downside
300009
Anhui Anke Biotechnology Group Co Ltd
28% Upside
OPK
OPKO Health Inc
135% Upside
9926
Akeso Inc
8% Upside
IMNM
Immunome Inc
190% Upside

Revenue
Forecast

Revenue Estimate
Carisma Therapeutics Inc

For the last 8 years the compound annual growth rate for Carisma Therapeutics Inc's revenue is -5%.

-5%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Carisma Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Carisma Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CARM's stock price target?
Price Target
1.02 USD

According to Wall Street analysts, the average 1-year price target for CARM is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Back to Top